Citations

Clear

4207 citation(s) found for "Chen, Yu".

Gene knockout of the KCNJ8‐encoded Kir6.1 K ATP channel imparts fatal susceptibility to endotoxemia
Kane, Garvan C. , Lam, Chen‐Fuh , O’Cochlain, Fearghas, Hodgson, Denice M., Reyes, Santiago , Liu, Xiaoke , Seino, Susumu , Katušić, Zvonimir S. , Miki, Takashi , Terzic, André , Liu, Xiaoke

Mayo Clinic

The FASEB Journal | October 31, 2006 | Volume: 20 | Issue: 13 | Pages: 2271-2280

10.1096/fj.06-6349com | PMID 17077304 Get It

Sepsis, the systemic inflammatory response to infection, imposes a high demand for bodily adaptation, with the cardiovascular response a key determinant of outcome. The homeostatic elements that secure cardiac tolerance in the setting of the sepsis syndrome are poorly understood. Here, in a model of acute septic shock induced by endotoxin challenge with Escherichia coli lipopolysaccharide (LPS), knockout of the KCNJ8 gene encoding the vascular Kir6.1 K ATP channel pore predisposed to an early and profound survival disadvantage. The exaggerated susceptibility provoked by disruption of this stress‐responsive sensor of cellular metabolism was linked to progressive deterioration in cardiac activity, ischemic myocardial damage, and contractile dysfunction. Deletion of KCNJ8 blunted the responsiveness of coronary vessels to cytokine‐ or metabolic‐mediated vasodilation necessary to support myocardial perfusion in the wild‐type (WT), creating a deficit in adaptive response in the Kir6.1 knockout. Application of a K ATP channel opener drug improved survival in the endotoxic WT but had no effect in the Kir6.1 knockout. Restoration of the dilatory capacity of coronary vessels was required to rescue the Kir6.1 knockout phenotype and reverse survival disadvantage in lethal endotoxemia. Thus, the Kir6.1containing K ATP channel, by coupling vasoreactivity with metabolic demand, provides a vital feedback element for cardiovascular tolerance in endotoxic shock.—Kane, G. C., Lam, C‐F., O'Cochlain, F., Hodgson, D. M., Reyes, S., Liu, X‐K., Miki, T., Seino, S., Katusic, Z. S., Terzic, A. Gene knockout of the KCNJ8encoded Kir6.1 KATP channel imparts fatal susceptibility to endotoxemia. FASEB J. 20, 2271–2280 (2006)
CDK2-Dependent Phosphorylation of FOXO1 as an Apoptotic Response to DNA Damage
Regan, Kevin M., Tindall, Donald J., Huang, Haojie , Lou, Zhenkun , Chen, Junjie

Mayo Clinic

Science | October 12, 2006 | Volume: 314 | Issue: 5797 | Pages: 294-297

10.1126/science.1130512 | PMID 17038621 Get It

The function of cyclin-dependent kinase 2 (CDK2) is often abolished after DNA damage. The inhibition of CDK2 plays a central role in DNA damage–induced cell cycle arrest and DNA repair. However, whether CDK2 also influences the survival of cells under genotoxic stress is unknown. Forkhead box O (FOXO) transcription factors are emerging as key regulators of cell survival. CDK2 specifically phosphorylated FOXO1 at serine-249 (Ser 249 ) in vitro and in vivo. Phosphorylation of Ser 249 resulted in cytoplasmic localization and inhibition of FOXO1. This phosphorylation was abrogated upon DNA damage through the cell cycle checkpoint pathway that is dependent on the protein kinases Chk1 and Chk2. Moreover, silencing of FOXO1 by small interfering RNA diminished DNA damage–induced death in both p53-deficient and p53-proficient cells. This effect was reversed by restored expression of FOXO1 in a manner depending on phosphorylation of Ser 249 . Functional interaction between CDK2 and FOXO1 provides a mechanism that regulates apoptotic cell death after DNA strand breakage.
Vitamin D–Mediated Hypercalcemia in Slack Skin Disease: Evidence for Involvement of Extrarenal 25-Hydroxyvitamin D 1α-Hydroxylase
Karakelides, Helen, Geller, Jordan L., Schroeter, Arnold L., Chen, Hong , Behn, P, Adams, John S. , Hewison, Martin , Wermers, Robert A.

Mayo Clinic

Journal of Bone and Mineral Research | August 30, 2006 | Volume: 21 | Issue: 9 | Pages: 1496-1499

10.1359/jbmr.060608 | PMID 16939409 Get It

Abstract A case of granulomatous slack skin disease is presented in which we studied the possible involvement of extrarenal 1,25(OH)2D in the pathogenesis of the patient's hypercalcemia. Immunolocalization of 1α-OH in skin showed simultaneous dysregulation in epithelial and granulomatous cells. Introduction: Granuloma-forming diseases such as sarcoidosis are associated with extrarenal synthesis of active 1,25-dihydroxyvitamin D [1,25(OH)2D]. Here we describe a case of granulomatous slack skin disease in which we have studied the possible involvement of extrarenal synthesis of 1,25(OH)2D in the pathogenesis of the patient's hypercalcemia. The aim of the study was to clarify the etiology of hypercalcemia in this patient. Materials and Methods: This was a case study of a 19-year-old man with a T-cell lymphoproliferative disorder diagnosed as granulomatous slack skin disease who presented with hypercalcemia and raised serum 1,25(OH)2D. Analysis of expression of the enzyme 25-hydroxyvitamin D 1α-hydroxylase (1α-hydroxylase), which catalyzes synthesis of 1,25(OH)2D, was carried out by immunohistochemical analysis of involved and uninvolved skin. Approval was granted by the Mayo Foundation Institutional Review Board and Biospecimens Subcommittee. Results: In uninvolved skin, expression of 1α-hydroxylase was confined to the basal layer of the epidermis, whereas slack skin showed overexpression of the enzyme in dermal granulomata and basal cells of the epidermis. Conclusions: Hypercalcemia associated with granulomatous slack skin syndrome seems to be caused by dysregulation of 1α-hydroxylase expression in both epidermal and dermal granulomatous cells. This contrasts with psoriasis and sarcoidosis of the skin, in which overexpression of the enzyme is restricted to keratinocytes and granulomata, respectively.
IC–P–045: Using partial–least squares to demonstrate a correlation between combined PET/MRI scores and apolipoprotein E ϵ4 gene dose
Reiman, Eric M. , Alexander, Gene E. , Caselli, Richard J., Bandy, Dan, Chen, Kewei

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_22 | Pages: No page available

10.1016/j.jalz.2006.05.2250 Get It

IC–P–025: Regional network pattern of MRI gray matter volume in Alzheimer's dementia
Alexander, Gene E. , Aschenbrenner, Melaney, Reiman, Eric M. , Caselli, Richard J., Rapoport, Stanley I., Moeller, James R., Chen, Kewei , Merkley, Tricia L. , Lewis, Diana J. , Pietrini, Pietro , Teipel, Stefan Johannes , Hampel, Harald

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_21 | Pages: No page available

10.1016/j.jalz.2006.05.2230 Get It

Surgical interventions for bilateral congenital cataract
Long, Vernon, Chen, Sean , Hatt, Sarah R.

Mayo Clinic

Cochrane Database of Systematic Reviews | July 18, 2006 | Volume: 2008 | Issue: 4 | Pages: No page available

10.1002/14651858.cd003171.pub2 | PMID 16855998 Get It

Transhepatic Puncture of Portal and Hepatic Veins for TIPS Using a Single-Needle Pass Under Sonographic Guidance
Raza, Syed Atif, Walser, Eric , Hernández, A , Chen, Keven, Marroquin, Santiago

Mayo Clinic

American Journal of Roentgenology | June 22, 2006 | Volume: 187 | Issue: 1 | Pages: W87-W91

10.2214/ajr.05.1342 | PMID 16794144 Get It

CP110 Cooperates with Two Calcium-binding Proteins to Regulate Cytokinesis and Genome Stability
Tsang, William Y.W. , Spektor, Alexander , Luciano, D, Indjeian, Vahan B. , Chen, Zhihong , Salisbury, Jeffery L., Sánchez, Irma, Dynlacht, Brian David

Mayo Clinic

Molecular Biology of the Cell | June 7, 2006 | Volume: 17 | Issue: 8 | Pages: 3423-3434

10.1091/mbc.e06-04-0371 | PMID 16760425 Get It

The centrosome is an integral component of the eukaryotic cell cycle machinery, yet very few centrosomal proteins have been fully characterized to date. We have undertaken a series of biochemical and RNA interference (RNAi) studies to elucidate a role for CP110 in the centrosome cycle. Using a combination of yeast two-hybrid screens and biochemical analyses, we report that CP110 interacts with two different Ca 2+ -binding proteins, calmodulin (CaM) and centrin, in vivo. In vitro binding experiments reveal a direct, robust interaction between CP110 and CaM and the existence of multiple high-affinity CaM-binding domains in CP110. Native CP110 exists in large (∼300 kDa to 3 MDa) complexes that contain both centrin and CaM. We investigated a role for CP110 in CaM-mediated events using RNAi and show that its depletion leads to a failure at a late stage of cytokinesis and the formation of binucleate cells, mirroring the defects resulting from ablation of either CaM or centrin function. Importantly, expression of a CP110 mutant unable to bind CaM also promotes cytokinesis failure and binucleate cell formation. Taken together, our data demonstrate a functional role for CaM binding to CP110 and suggest that CP110 cooperates with CaM and centrin to regulate progression through cytokinesis.
AJR Teaching File: Acute Abdominal Pain After Combined Kidney and Pancreas Transplantation
Silva, Alvin C. , Chen, Frederick

Mayo Clinic

American Journal of Roentgenology | May 19, 2006 | Volume: 186 | Issue: 6_supplement_1 | Pages: S452-S455

10.2214/ajr.05.1156 | PMID 16714625 Get It

Transforming Growth Factor-β Regulation of the Insulin-Like Growth Factor Binding Protein-4 Protease System in Cultured Human Osteoblasts
Ortiz, Christopher O., Chen, Bingkun , Bale, Laurie K., Overgaard, Michael T. , Oxvig, Claus , Conover, Cheryl A.

Mayo Clinic

Journal of Bone and Mineral Research | April 26, 2006 | Volume: 18 | Issue: 6 | Pages: 1066-1072

10.1359/jbmr.2003.18.6.1066 | PMID 12817760 Get It

Abstract IGFBP-4 is an inhibitor of IGF-I in bone. We show that TGF-β regulates IGFBP-4 and enhances IGF-I-stimulated growth of cultured human bone cells through increased expression of an IGFBP-4 protease, PAPP-A. This effect of TGF-β on IGF-I bioavailability may promote local bone formation. Insulin-like growth factor binding protein (IGFBP-4) proteolysis is implicated in the regulation of local insulin-like growth factor (IGF)-I bioavailability during bone remodeling. The IGFBP-4 protease secreted by normal adult human osteoblastic (hOB) cells in culture is a novel metalloproteinase, pregnancy-associated plasma protein-A (PAPP-A). We have recently identified an inhibitor of PAPP-A, the precursor form of major basic protein (proMBP). Very little is known about the molecular regulation of this IGFBP-4 protease system. In the present study, we determined the effect of transforming growth factor (TGF)-β and IGF-II, the two most abundant growth factors in human bone, on PAPP-A and proMBP expression in primary cultures of hOB cells. Treatment with TGF-β resulted in time- and dose-dependent increases in PAPP-A mRNA expression, with a maximal 12-fold increase after 24 h of stimulation with 10 ng/ml TGF-β. Increased PAPP-A levels in hOB cell-conditioned medium paralleled PAPP-A gene expression. In addition, TGF-β completely suppressed proMBP expression. Treatment of hOB cells with IGF-II had no effect on PAPP-A or proMBP gene expression. However, IGFBP-4 proteolysis in cell-free assay was dependent on IGF-II, and there was increased IGF-II-dependent IGFBP-4 protease activity in conditioned medium from hOB cells that were treated with TGF-β. IGF-I stimulation of hOB cell proliferation was markedly enhanced by pretreatment with TGF-β and [Leu27]IGF-II, and this enhancement was prevented with protease-resistant IGFBP-4. In summary, TGF-β regulates IGFBP-4 proteolysis in hOB cells through increased expression of the protease, PAPP-A, and decreased expression of the inhibitor, proMBP. However, functional activation of the IGFBP-4 protease system is dependent on IGF-II, which acts at a post-translational level. These data support a model whereby local TGF-β and IGF-II in the bone microenvironment coordinately amplify IGF-I bioavailability through controlled IGFBP-4 proteolysis, which may be a means to promote bone formation.